GDUFA Research Outcomes
QCP Methods
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to quantitative clinical pharmacology assessments of oral absorption to support generic product development and assessment.
-
Using a Physiologically Based Pharmacokinetic Absorption Model to Establish Dissolution Bioequivalence Safe Space for Oseltamivir in Adult and Pediatric Populations
Wu, Fang
-
EMA Discussion on Levothyroxine NTI Classification and BE Approach
Donnelly, Mark
-
Partial Area Under Curve (pAUC): Product-Specific Guidance Development
Fang, Lanyan (Lucy)
-
Applications and Lessons Learned for Conducting Adaptive Designs in Generic Drug Development
Feng, Kairui
-
Comparative, Crossover PD Study of d|Different Formulations of Extended Release MPH
Spencer, Thomas; Biederman, Joseph; Faraone, SV; Childress, Ann; Gomeni, Roberto; Babiskin, Andrew; Fang, Lucy
-
Virtual Bioequivalence Workflow
Pellowe, M
-
Application of Quantitative Clinical Pharmacology (QCP) in Development of Long Acting Injectable Products
Sharan, Satish
-
Application of Modeling and Simulation in Establishing Appropriate Bioequivalence Limits for Complex Formulations
Sharan, Satish
-
Evaluation Of Residual Levonorgestrel As Potential Bioequivalence Metric For A Long Acting Intrauterine System Using Quantitative Modeling And Simulation Approach
Sharan, Satish
-
Model-Integrated Methods and Innovative Study Designs for Generic LAI Product Development and Regulatory Assessment
Hooker, Andrew